BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7161788)

  • 1. JPC-80, a new slow acting antirheumatoid drug.
    Norton WL; Donnelly RJ; Schimmelpfennig W; Harden JA
    J Rheumatol; 1982; 9(6):951-3. PubMed ID: 7161788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pyrithioxine: a new basic treatment of rheumatoid arthritis. Open study of 60 cases with a follow-up of 6 months].
    Camus JP; Jaffe IA; Crouzet J; Prier A; Stephan JC; Laveant C
    Ann Med Interne (Paris); 1977 Dec; 128(12):907-11. PubMed ID: 603171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pyrithioxine a new basic treatment of rheumatoid polyarthritis: initial study of 72 cases with a 6-month follow-up].
    Camus JP; Jaffe IA; Crouzet J; Prier A; Mercier A; Dubois A
    Rev Rhum Mal Osteoartic; 1978 Feb; 45(2):95-100. PubMed ID: 644244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of 70 cases of rheumatoid polyarthritis treated by pyrithioxin with a 1-year follow-up].
    Camus JP; Crouzet J; Prier A; Bergevin H
    Rev Rhum Mal Osteoartic; 1978; 45(7-9):487-90. PubMed ID: 725465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and immunological effects of treatment of rheumatoid arthritis with pyrithioxin (Enerbol Polfa)].
    Brühl W; Swierczyńska Z; Szymańska-Cygler B; Dyznarowska H; Chrzczonowski Z; Loth E; Zabek J
    Reumatologia; 1980; 18(3):241-8. PubMed ID: 6448464
    [No Abstract]   [Full Text] [Related]  

  • 6. [Side effects of D-penicillamine and pyritinol. Cooperative study among French hospital drug surveillance centers].
    Netter P; Tréchot P; Bannwarth B; Faure G; Royer RJ
    Therapie; 1985; 40(6):475-9. PubMed ID: 4089789
    [No Abstract]   [Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nephrotic syndrome related to the use of pyrithioxin in the treatment of rheumatoid arthritis].
    Amor B; Cherot A; Delbarre F
    Nouv Presse Med; 1979 Jun; 8(24):2023-4. PubMed ID: 492994
    [No Abstract]   [Full Text] [Related]  

  • 9. [Retrospective study of the effects of D-penicillamine and pyrithioxin in the treatment of rheumatoid arthritis].
    Clerc D; Sallière D; Segond P; Bisson M; Massias P
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):281-7. PubMed ID: 6879095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lichenoid eruption during the treatment of rheumatoid arthritis with pyrithioxin].
    Crouzet J; Fourot J; Julie JH; Duterque M
    Rev Rhum Mal Osteoartic; 1983 Dec; 50(12):827-8. PubMed ID: 6229868
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nephrotic syndrome during rheumatoid polyarthritis treated with pyrithioxin].
    Segond P; Dellas JA; Massias P; Delfraissy JF
    Rev Rhum Mal Osteoartic; 1979; 46(7-9):509-10. PubMed ID: 504954
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myasthenia induced by pyrithioxine during the treatment of rheumatoid arthritis].
    Kirjner M; Lebourges J; Camus JP
    Nouv Presse Med; 1980 Nov; 9(41):3098. PubMed ID: 7443460
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sulfhydryl maintenance treatment in rheumatoid polyarthritis. A series of 120 cases followed for 10 years and a study of possibilities of changing the drug].
    Camus JP; Koeger AC; Struz P; Laveant C
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):31-3. PubMed ID: 3704509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrithioxine and thiopronine: new penicillamine-like drugs in rheumatoid arthritis.
    Camus JP; Crouzet J; Prier A; Bergevin H
    J Rheumatol Suppl; 1981; 7():175-7. PubMed ID: 6939882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of a long acting somatostatin analogue for the treatment of refractory rheumatoid arthritis.
    Paran D; Elkayam O; Mayo A; Paran H; Amit M; Yaron M; Caspi D
    Ann Rheum Dis; 2001 Sep; 60(9):888-91. PubMed ID: 11502617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis.
    Moreland LW; Margolies G; Heck LW; Saway A; Blosch C; Hanna R; Koopman WJ
    J Rheumatol; 1996 Nov; 23(11):1849-55. PubMed ID: 8923355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two cases of superficial pemphigus induced by pyritinol (author's transl)].
    Civatte J; Duterque M; Blanchet P; Belaïch S; Lazarovici C; Morel P; Foix C; Fischesser D
    Ann Dermatol Venereol; 1978; 105(6-7):573-7. PubMed ID: 736425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamitinol in paedopsychiatric out-patient therapy.
    Sanz R; Bettschart W; Reinhardt B
    Pharmatherapeutica; 1981; 3(1):40-5. PubMed ID: 7323108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy.
    Kavanaugh A; St Clair EW; McCune WJ; Braakman T; Lipsky P
    J Rheumatol; 2000 Apr; 27(4):841-50. PubMed ID: 10782805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.